ANGIODYNAMICS INC (ANGO)

ANGIODYNAMICS INC (ANGO) is a publicly traded medical device manufacturer focused on products used in vascular interventional and oncology procedures. The company develops and commercializes minimally invasive technologies deployed by interventional radiologists, cardiologists, surgeons, and oncologists in hospital and outpatient settings.

What the company does

ANGIODYNAMICS manufactures medical devices used in minimally invasive procedures across three primary product categories: vascular access systems, imaging solutions, and ablation platforms. Its vascular access portfolio includes central venous catheters, implantable ports, and insertion kits used to establish reliable access points for chemotherapy, dialysis, blood sampling, and nutritional support. The imaging segment provides contrast media delivery systems and related accessories. Its oncology division focuses on ablation technologies—including radiofrequency and microwave systems—used to treat solid tumors. These products serve interventional radiology practices, surgical centers, hospitals, and cancer treatment facilities.

How it makes money

The company generates revenue through direct sales of medical devices to hospitals, surgical centers, and specialty clinics, supplemented by recurring revenue from disposable components and consumables. Device sales represent the primary revenue stream, with oncology ablation systems and vascular access products forming the core of the business. The company also derives income from service agreements and training programs tied to its installed base of capital equipment. International sales contribute a material portion of total revenue, extending the company’s market presence beyond North America.

Where it sits in its industry

ANGIODYNAMICS competes in the fragmented medical device sector, primarily against larger diversified device manufacturers (such as Boston Scientific, Medtronic, and Teleflex) as well as specialized firms in vascular access and interventional oncology. The company holds a differentiated position in niche segments where its technologies have established clinical utility and customer loyalty, but it faces ongoing competition from both established incumbents and emerging startups. Its scale is smaller than market leaders, which constrains research and development spending and limits its ability to fund large-scale clinical trials; conversely, its focus on specific procedure types and clinical communities allows targeted commercial strategies unavailable to broader competitors.

How to research it

Begin with the company’s annual 10-K filing and quarterly 10-Q reports filed with the SEC, which detail business operations, competitive positioning, financial performance, and risk factors. Review earnings call transcripts and guidance commentary to understand management’s view of market trends and product adoption. For clinical validation, examine peer-reviewed journal articles discussing the clinical outcomes and safety profile of ANGIODYNAMICS products in published studies. Industry databases and healthcare research reports from firms specializing in medical device markets provide market size estimates and competitive benchmarking. Investor presentations and conference materials offer forward-looking perspectives on product pipeline and growth initiatives.